✦ LIBER ✦
A phase II study of oral etoposide (OE) 100 mg/day for 21 days (D) Q 5 weeks (W) in untreated elderly (E) and poor performance status (PPS) Small Cell Lung Cancer (SCLC) patients (pts)
- Book ID
- 122416051
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 150 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.